selegiline has been researched along with rotenone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HQ; Weng, EQ; Zhu, XZ | 1 |
| Mohanakumar, KP; Saravanan, KS; Senthilkumar, KS; Sindhu, KM | 1 |
| Cheng, X; Li, S; Liu, B; Lv, C; Ma, Y; Mao, W; Sun, J; Zhang, J | 1 |
| Bajaj, A; Gaud, R; Meshram, P; Sridhar, V; Wairkar, S | 1 |
| Fay-Karmon, T; Gutman-Sharabi, N; Halperin, R; Khashab, R; Landau, R; Leibowitz, A; Shabtai, Z; Sharabi, Y | 1 |
5 other study(ies) available for selegiline and rotenone
| Article | Year |
|---|---|
Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Dopamine; L-Lactate Dehydrogenase; Lactic Acid; Monoamine Oxidase Inhibitors; Oxidation-Reduction; PC12 Cells; Rats; Reactive Oxygen Species; Reserpine; Rotenone; Selegiline | 2005 |
L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Topics: Amphetamine; Animals; Catalase; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Electron Transport Complex I; Hydroxyl Radical; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Selegiline; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Uncoupling Agents; Up-Regulation | 2006 |
Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson's disease.
Topics: Animals; Apoptosis Regulatory Proteins; Beclin-1; Disease Models, Animal; Insecticides; Male; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Selegiline; Substantia Nigra; Time Factors | 2015 |
Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease.
Topics: Adhesiveness; Administration, Intranasal; Animals; Biological Availability; Brain; Drug Delivery Systems; Gels; Humans; Male; Nasal Mucosa; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotenone; Selegiline | 2018 |
Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease.
Topics: Acetylcysteine; Aldehyde Dehydrogenase; Animals; Dopamine; Monoamine Oxidase Inhibitors; Parkinson Disease; Rats; Rotenone; Selegiline | 2023 |